We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Reduction of Oncogene Activity Causes Cancer Cells to Revert to Normal

By Biotechdaily staff writers
Posted on 09 Jul 2008
Cancer researchers working with a mouse model have found that by reducing the activity of the Myc oncogene, they could reverse the uncontrolled growth of cancer cells and return them to a normal, healthy state.

All normal cells require Myc activity. More...
However, Myc overexpression causes cells to grow too large and multiply uncontrollably. Previous studies have shown that eliminating Myc caused the death of tumor cells but had the same effect on normal tissues.

In the current study investigators at Stanford University (Palo Alto, CA, USA) worked with mice that had been genetically engineered to develop Myc-driven tumors in response to a chemical in their drinking water. After triggering tumor development at high levels of Myc activity, they gradually reduced the level of Myc. During this process they monitored both the genomic - oligonucleotide microarray analysis and quantitative PCR were used to identify changes in expression in 3,921 genes – and proteomic status of the cells. In the latter case, two-dimensional protein analysis followed by mass spectrometry, phospho-flow fluorescence-activated cell sorting, and antibody arrays were employed.

Results published in the July 1, 2008, issue of the journal Cancer Research revealed that as the Myc concentration reached the critical level where cancer cells began to revert to normal 2,348 genes were down-regulated while 1,573 were up-regulated, and proteins involved in mRNA translation decreased. In short, at the MYC threshold level, there was a loss of the oncogene's ability to maintain tumorigenesis, with associated shifts in gene and protein expression that reestablished cell cycle checkpoints, halted protein translation, and promoted apoptosis.

"In the past, scientists have shown that cancer signals such as Myc are like light switches,” said senior author Dr. Dean Felsher, associate professor of oncology and pathology at Stanford University. "Now we know that, in some cases, you do not need to turn the light completely off. We were able to experimentally prove that we can turn Myc off a little bit, or for a little time, and that is enough to have a profound effect on cancer.”


Related Links:
Stanford University

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Alzheimer's Disease Biomarker Assay
Elecsys Phospho-Tau (217P) Plasma
Hematology Consumables
Bioblood Devices
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders

Severe pneumococcal disease requiring hospitalization often presents as pneumonia, particularly in older adults and people with cancer or compromised immune function. Because M protein testing and antibody... Read more

Microbiology

view channel
Image Credit: 123RF

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.